NO20002218L - Anvendelse av mirtazepin for behandling av søvnapne - Google Patents

Anvendelse av mirtazepin for behandling av søvnapne

Info

Publication number
NO20002218L
NO20002218L NO20002218A NO20002218A NO20002218L NO 20002218 L NO20002218 L NO 20002218L NO 20002218 A NO20002218 A NO 20002218A NO 20002218 A NO20002218 A NO 20002218A NO 20002218 L NO20002218 L NO 20002218L
Authority
NO
Norway
Prior art keywords
mirtazepine
treatment
sleep apnea
mirtazapine
fluoxetin
Prior art date
Application number
NO20002218A
Other languages
English (en)
Norwegian (no)
Other versions
NO20002218D0 (no
Inventor
John Stuart Andrews
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20002218D0 publication Critical patent/NO20002218D0/no
Publication of NO20002218L publication Critical patent/NO20002218L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/16—Central respiratory analeptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NO20002218A 1997-11-14 2000-04-28 Anvendelse av mirtazepin for behandling av søvnapne NO20002218L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97203548 1997-11-14
PCT/EP1998/007330 WO1999025356A1 (en) 1997-11-14 1998-11-13 Use of mirtazapine for treating sleep apneas

Publications (2)

Publication Number Publication Date
NO20002218D0 NO20002218D0 (no) 2000-04-28
NO20002218L true NO20002218L (no) 2000-05-12

Family

ID=8228923

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20002218A NO20002218L (no) 1997-11-14 2000-04-28 Anvendelse av mirtazepin for behandling av søvnapne

Country Status (21)

Country Link
US (1) US6303595B1 (de)
EP (1) EP1030667B1 (de)
JP (1) JP2001522891A (de)
KR (1) KR20010032009A (de)
CN (1) CN1154495C (de)
AT (1) ATE289816T1 (de)
AU (1) AU737590B2 (de)
BR (1) BR9815098A (de)
CA (1) CA2309744A1 (de)
CZ (1) CZ296282B6 (de)
DE (1) DE69829202T2 (de)
DK (1) DK1030667T3 (de)
ES (1) ES2238781T3 (de)
HK (1) HK1029932A1 (de)
HU (1) HUP0100080A3 (de)
IL (2) IL135825A0 (de)
NO (1) NO20002218L (de)
PL (1) PL192272B1 (de)
PT (1) PT1030667E (de)
TR (1) TR200001293T2 (de)
WO (1) WO1999025356A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060241164A1 (en) * 1998-02-27 2006-10-26 The Board Of Trustees Of The University Of Illinoi Pharmacological treatment for sleep apnea
CA2321900C (en) 1998-02-27 2011-07-19 The Board Of Trustees Of The University Of Illinois Agents with serotonin-related activity for the treatment for sleep apnea
US7160898B2 (en) * 2001-12-14 2007-01-09 Board Of Trustees Of The University Of Illinois Pharmacological treatment for sleep apnea
CA2396209C (en) * 2000-02-11 2009-09-01 Akzo Nobel N.V. The use of mirtazapine for the treatment of sleep disorders
US20020183306A1 (en) * 2001-05-30 2002-12-05 Pfizer Inc. Combination treatment for sleep disorders including sleep apnea
UA83666C2 (ru) 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
US7838029B1 (en) 2003-07-31 2010-11-23 Watson Laboratories, Inc. Mirtazapine solid dosage forms
WO2005023767A2 (en) 2003-09-10 2005-03-17 Brentwood Equities Ltd. Diastereomers of 4-aryloxy-3-hydroxypiperidines
WO2006023702A2 (en) * 2004-08-20 2006-03-02 Cypress Bioscience, Inc. Method for treating sleep related breathing disorders with setiptiline
WO2006055854A2 (en) * 2004-11-17 2006-05-26 Cypress Bioscience, Inc. Methods for reducing the side effects associated with mirtazapine treatment
US8512751B2 (en) 2004-12-20 2013-08-20 Collegium Pharmaceutical, Inc. Pharmaceutical compositions for sleep disorders
JP5635905B2 (ja) 2007-04-11 2014-12-03 メルク・シャープ・エンド・ドーム・ベー・フェー ミルタザピンの調製方法
WO2008157094A1 (en) * 2007-06-13 2008-12-24 Cypress Bioscience, Inc. Improving the tolerability of mirtazapine and a second active by using them in combination
WO2013188806A1 (en) * 2012-06-14 2013-12-19 The Regents Of The University Of Michigan Sleep apnea treatment
PL3261645T3 (pl) 2015-02-27 2021-12-06 Dechra Limited Pobudzanie apetytu, zarządzanie utratą masy ciała, i leczenie anoreksji u psów i kotów

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4314081A (en) * 1974-01-10 1982-02-02 Eli Lilly And Company Arloxyphenylpropylamines
EP0517984A1 (de) 1991-06-11 1992-12-16 Merrell Dow Pharmaceuticals Inc. Amidanaloge-Derivate von methanoverbrückten Chinolizinen
EP0866711B1 (de) * 1995-10-24 2006-07-26 Grünenthal GmbH Montirelin zur verhinderung der schlafapnoe
SE9504537D0 (sv) * 1995-12-19 1995-12-19 Jan Hedner Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
US6117855A (en) * 1996-10-07 2000-09-12 Merck Sharp & Dohme Ltd. Use of a NK-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent

Also Published As

Publication number Publication date
CN1278731A (zh) 2001-01-03
CN1154495C (zh) 2004-06-23
KR20010032009A (ko) 2001-04-16
PL192272B1 (pl) 2006-09-29
DE69829202D1 (de) 2005-04-07
CZ20001751A3 (cs) 2000-10-11
HUP0100080A2 (hu) 2001-08-28
AU737590B2 (en) 2001-08-23
ATE289816T1 (de) 2005-03-15
IL135825A (en) 2006-12-31
CA2309744A1 (en) 1999-05-27
CZ296282B6 (cs) 2006-02-15
HUP0100080A3 (en) 2002-05-28
EP1030667A1 (de) 2000-08-30
DK1030667T3 (da) 2005-06-20
ES2238781T3 (es) 2005-09-01
EP1030667B1 (de) 2005-03-02
TR200001293T2 (tr) 2002-09-23
PT1030667E (pt) 2005-06-30
WO1999025356A1 (en) 1999-05-27
PL340467A1 (en) 2001-02-12
AU1754899A (en) 1999-06-07
IL135825A0 (en) 2001-05-20
DE69829202T2 (de) 2005-07-21
US6303595B1 (en) 2001-10-16
NO20002218D0 (no) 2000-04-28
BR9815098A (pt) 2000-10-10
HK1029932A1 (en) 2001-04-20
JP2001522891A (ja) 2001-11-20

Similar Documents

Publication Publication Date Title
NO20002218D0 (no) Anvendelse av mirtazepin for behandling av søvnapne
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
JO2475B1 (en) Glucokinase stimulants
AU5584901A (en) Use of cyclic gmp-specific phosphodiesterase inhibitors for treatment of parkinson's disease
ATE495736T1 (de) Verwendung von derivaten der 2-oxothiazolidin-4- corbonsäure als prä-abschuppungsmittel
CY1109229T1 (el) Χρηση σπογγοσινης (2-μεθοξυαδενοσινης) για τη θεραπεια πονου, συγκεκριμενα υπερευαισθησιας στο πονο
HK1080467A1 (en) Benzofuran and benzothiophene derivatives useful in the treatment of hyper-proliferative disorders
DE60028010D1 (de) Verminderung des haarwuchses
EE200200337A (et) Uued ühendid ning nende kasutamine
SE0004101D0 (sv) New use
DK1610864T3 (da) Elektromagnetisk stimulering af patienter med osteoporose
UY26085A1 (es) N-[-(4-aminofenil)-2,3-dihidro-1,4-benzodioxina-2-metanamina su preparacion y su aplicacion en terapeutica
ZA9711468B (en) New use of comt inhibitors
ATE262362T1 (de) Verwendung von cyamemazin zur behandlung von entwöhnungserscheinungen der benzodiazepinbehandlung
SE9800139D0 (sv) New use
ATE302023T1 (de) Verwendung von stickstoffoxid zur behandlung von atemwegs-verengungen
ATE423780T1 (de) Makrozyclen zur behandlung von krebserkrankungen
NO20062138L (no) Anvendelse av ifenprodil i behandling av smerte
SE9802207D0 (sv) Novel compounds
UA38987A (uk) Спосіб лікування піодермії
EA200501053A1 (ru) Производные 1,2,4-триаминобензола, пригодные для лечения расстройств центральной нервной системы

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application